Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ivosidenib market report explains the definition, types, applications, major countries, and major players of the Ivosidenib market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Agios Pharmaceuticals
By Type:
60 Tablets
30 Tablets
By End-User:
Hospital
Pharmacy
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Ivosidenib Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Ivosidenib Outlook to 2028- Original Forecasts
-
2.2 Ivosidenib Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Ivosidenib Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Ivosidenib Market- Recent Developments
-
6.1 Ivosidenib Market News and Developments
-
6.2 Ivosidenib Market Deals Landscape
7 Ivosidenib Raw Materials and Cost Structure Analysis
-
7.1 Ivosidenib Key Raw Materials
-
7.2 Ivosidenib Price Trend of Key Raw Materials
-
7.3 Ivosidenib Key Suppliers of Raw Materials
-
7.4 Ivosidenib Market Concentration Rate of Raw Materials
-
7.5 Ivosidenib Cost Structure Analysis
-
7.5.1 Ivosidenib Raw Materials Analysis
-
7.5.2 Ivosidenib Labor Cost Analysis
-
7.5.3 Ivosidenib Manufacturing Expenses Analysis
8 Global Ivosidenib Import and Export Analysis (Top 10 Countries)
-
8.1 Global Ivosidenib Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Ivosidenib Export by Region (Top 10 Countries) (2017-2028)
9 Global Ivosidenib Market Outlook by Types and Applications to 2022
-
9.1 Global Ivosidenib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 60 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 30 Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Ivosidenib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Ivosidenib Market Analysis and Outlook till 2022
-
10.1 Global Ivosidenib Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Ivosidenib Consumption (2017-2022)
-
10.2.2 Canada Ivosidenib Consumption (2017-2022)
-
10.2.3 Mexico Ivosidenib Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Ivosidenib Consumption (2017-2022)
-
10.3.2 UK Ivosidenib Consumption (2017-2022)
-
10.3.3 Spain Ivosidenib Consumption (2017-2022)
-
10.3.4 Belgium Ivosidenib Consumption (2017-2022)
-
10.3.5 France Ivosidenib Consumption (2017-2022)
-
10.3.6 Italy Ivosidenib Consumption (2017-2022)
-
10.3.7 Denmark Ivosidenib Consumption (2017-2022)
-
10.3.8 Finland Ivosidenib Consumption (2017-2022)
-
10.3.9 Norway Ivosidenib Consumption (2017-2022)
-
10.3.10 Sweden Ivosidenib Consumption (2017-2022)
-
10.3.11 Poland Ivosidenib Consumption (2017-2022)
-
10.3.12 Russia Ivosidenib Consumption (2017-2022)
-
10.3.13 Turkey Ivosidenib Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Ivosidenib Consumption (2017-2022)
-
10.4.2 Japan Ivosidenib Consumption (2017-2022)
-
10.4.3 India Ivosidenib Consumption (2017-2022)
-
10.4.4 South Korea Ivosidenib Consumption (2017-2022)
-
10.4.5 Pakistan Ivosidenib Consumption (2017-2022)
-
10.4.6 Bangladesh Ivosidenib Consumption (2017-2022)
-
10.4.7 Indonesia Ivosidenib Consumption (2017-2022)
-
10.4.8 Thailand Ivosidenib Consumption (2017-2022)
-
10.4.9 Singapore Ivosidenib Consumption (2017-2022)
-
10.4.10 Malaysia Ivosidenib Consumption (2017-2022)
-
10.4.11 Philippines Ivosidenib Consumption (2017-2022)
-
10.4.12 Vietnam Ivosidenib Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Ivosidenib Consumption (2017-2022)
-
10.5.2 Colombia Ivosidenib Consumption (2017-2022)
-
10.5.3 Chile Ivosidenib Consumption (2017-2022)
-
10.5.4 Argentina Ivosidenib Consumption (2017-2022)
-
10.5.5 Venezuela Ivosidenib Consumption (2017-2022)
-
10.5.6 Peru Ivosidenib Consumption (2017-2022)
-
10.5.7 Puerto Rico Ivosidenib Consumption (2017-2022)
-
10.5.8 Ecuador Ivosidenib Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Ivosidenib Consumption (2017-2022)
-
10.6.2 Kuwait Ivosidenib Consumption (2017-2022)
-
10.6.3 Oman Ivosidenib Consumption (2017-2022)
-
10.6.4 Qatar Ivosidenib Consumption (2017-2022)
-
10.6.5 Saudi Arabia Ivosidenib Consumption (2017-2022)
-
10.6.6 United Arab Emirates Ivosidenib Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Ivosidenib Consumption (2017-2022)
-
10.7.2 South Africa Ivosidenib Consumption (2017-2022)
-
10.7.3 Egypt Ivosidenib Consumption (2017-2022)
-
10.7.4 Algeria Ivosidenib Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Ivosidenib Consumption (2017-2022)
-
10.8.2 New Zealand Ivosidenib Consumption (2017-2022)
11 Global Ivosidenib Competitive Analysis
-
11.1 Agios Pharmaceuticals
-
11.1.1 Agios Pharmaceuticals Company Details
-
11.1.2 Agios Pharmaceuticals Ivosidenib Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Agios Pharmaceuticals Ivosidenib Main Business and Markets Served
-
11.1.4 Agios Pharmaceuticals Ivosidenib Product Portfolio
-
11.1.5 Recent Research and Development Strategies
12 Global Ivosidenib Market Outlook by Types and Applications to 2028
-
12.1 Global Ivosidenib Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 60 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 30 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Ivosidenib Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Ivosidenib Market Analysis and Outlook to 2028
-
13.1 Global Ivosidenib Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Ivosidenib Consumption Forecast (2022-2028)
-
13.2.2 Canada Ivosidenib Consumption Forecast (2022-2028)
-
13.2.3 Mexico Ivosidenib Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Ivosidenib Consumption Forecast (2022-2028)
-
13.3.2 UK Ivosidenib Consumption Forecast (2022-2028)
-
13.3.3 Spain Ivosidenib Consumption Forecast (2022-2028)
-
13.3.4 Belgium Ivosidenib Consumption Forecast (2022-2028)
-
13.3.5 France Ivosidenib Consumption Forecast (2022-2028)
-
13.3.6 Italy Ivosidenib Consumption Forecast (2022-2028)
-
13.3.7 Denmark Ivosidenib Consumption Forecast (2022-2028)
-
13.3.8 Finland Ivosidenib Consumption Forecast (2022-2028)
-
13.3.9 Norway Ivosidenib Consumption Forecast (2022-2028)
-
13.3.10 Sweden Ivosidenib Consumption Forecast (2022-2028)
-
13.3.11 Poland Ivosidenib Consumption Forecast (2022-2028)
-
13.3.12 Russia Ivosidenib Consumption Forecast (2022-2028)
-
13.3.13 Turkey Ivosidenib Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Ivosidenib Consumption Forecast (2022-2028)
-
13.4.2 Japan Ivosidenib Consumption Forecast (2022-2028)
-
13.4.3 India Ivosidenib Consumption Forecast (2022-2028)
-
13.4.4 South Korea Ivosidenib Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Ivosidenib Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Ivosidenib Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Ivosidenib Consumption Forecast (2022-2028)
-
13.4.8 Thailand Ivosidenib Consumption Forecast (2022-2028)
-
13.4.9 Singapore Ivosidenib Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Ivosidenib Consumption Forecast (2022-2028)
-
13.4.11 Philippines Ivosidenib Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Ivosidenib Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Ivosidenib Consumption Forecast (2022-2028)
-
13.5.2 Colombia Ivosidenib Consumption Forecast (2022-2028)
-
13.5.3 Chile Ivosidenib Consumption Forecast (2022-2028)
-
13.5.4 Argentina Ivosidenib Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Ivosidenib Consumption Forecast (2022-2028)
-
13.5.6 Peru Ivosidenib Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Ivosidenib Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Ivosidenib Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Ivosidenib Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Ivosidenib Consumption Forecast (2022-2028)
-
13.6.3 Oman Ivosidenib Consumption Forecast (2022-2028)
-
13.6.4 Qatar Ivosidenib Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Ivosidenib Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Ivosidenib Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Ivosidenib Consumption Forecast (2022-2028)
-
13.7.2 South Africa Ivosidenib Consumption Forecast (2022-2028)
-
13.7.3 Egypt Ivosidenib Consumption Forecast (2022-2028)
-
13.7.4 Algeria Ivosidenib Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Ivosidenib Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Ivosidenib Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Ivosidenib
-
Figure of Ivosidenib Picture
-
Table Global Ivosidenib Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Ivosidenib Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 60 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 30 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Ivosidenib Consumption by Country (2017-2022)
-
Table North America Ivosidenib Consumption by Country (2017-2022)
-
Figure United States Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Canada Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Mexico Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table Europe Ivosidenib Consumption by Country (2017-2022)
-
Figure Germany Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure UK Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Spain Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Belgium Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure France Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Italy Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Denmark Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Finland Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Norway Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Sweden Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Poland Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Russia Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Turkey Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table APAC Ivosidenib Consumption by Country (2017-2022)
-
Figure China Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Japan Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure India Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Thailand Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Singapore Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Philippines Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table South America Ivosidenib Consumption by Country (2017-2022)
-
Figure Brazil Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Colombia Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Chile Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Argentina Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Peru Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table GCC Ivosidenib Consumption by Country (2017-2022)
-
Figure Bahrain Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Oman Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Qatar Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table Africa Ivosidenib Consumption by Country (2017-2022)
-
Figure Nigeria Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure South Africa Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Egypt Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure Algeria Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table Oceania Ivosidenib Consumption by Country (2017-2022)
-
Figure Australia Ivosidenib Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Ivosidenib Consumption and Growth Rate (2017-2022)
-
Table Agios Pharmaceuticals Company Details
-
Table Agios Pharmaceuticals Ivosidenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agios Pharmaceuticals Ivosidenib Main Business and Markets Served
-
Table Agios Pharmaceuticals Ivosidenib Product Portfolio
-
Figure Global 60 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 30 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ivosidenib Consumption Forecast by Country (2022-2028)
-
Table North America Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure United States Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure Germany Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure China Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure Brazil Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Ivosidenib Consumption Forecast by Country (2022-2028)
-
Figure Australia Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Ivosidenib Consumption Forecast and Growth Rate (2022-2028)
-
